By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GTx, Inc. 

3 N. Dunlap Avenue, Third Floor

Memphis  Tennessee  38163  U.S.A.
Phone: 901-523-9700 Fax: 901-523-9772



Company News
GTx, Inc. (GTXI) To Present Results On Enobosarm 9mg In Women With Metastatic Breast Cancer At 2014 San Antonio Breast Cancer Symposium 12/8/2014 11:09:42 AM
GTx, Inc. (GTXI) Announces Closing Of $43.4 Private Placement 11/17/2014 5:32:34 PM
GTx, Inc. (GTXI) Banks $43.4 Million 11/10/2014 6:18:28 AM
GTx, Inc. (GTXI) To Host Third Quarter 2014 Financial Results Conference Call And Webcast 11/4/2014 9:57:26 AM
GTx, Inc. (GTXI) Announces Webcast of Corporate Presentation at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference 8/7/2014 10:55:09 AM
GTx, Inc. (GTXI) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/5/2014 9:55:18 AM
GTx, Inc. (GTXI) To Report Second Quarter 2014 Financial Results On August 5, 2014 7/22/2014 12:18:49 PM
GTx, Inc. (GTXI) Reports Positive Clinical Data From Open Label Phase 2 Study Of Enobosarm In Patients With Androgen And Estrogen Receptor Positive Metastatic Breast Cancer 6/2/2014 10:59:42 AM
SEC Accuses Two Doctors Of Insider Trading After GTx, Inc. (GTXI) Clinical Trial Is Halted 5/20/2014 8:47:40 AM
GTx, Inc. (GTXI) To Present Clinical Data On Enobosarm In Breast Cancer And NSCLC At B. Allen Group 2014 Annual Meeting 5/19/2014 6:53:05 AM